Hofste, L.S.M.; Geerlings, M.J.; von Rhein, D.; Tolmeijer, S.H.; Weiss, M.M.; Gilissen, C.; Hofste, T.; Garms, L.M.; Janssen, M.J.R.; Rütten, H.;
et al. Circulating Tumor DNA-Based Disease Monitoring of Patients with Locally Advanced Esophageal Cancer. Cancers 2022, 14, 4417.
https://doi.org/10.3390/cancers14184417
AMA Style
Hofste LSM, Geerlings MJ, von Rhein D, Tolmeijer SH, Weiss MM, Gilissen C, Hofste T, Garms LM, Janssen MJR, Rütten H,
et al. Circulating Tumor DNA-Based Disease Monitoring of Patients with Locally Advanced Esophageal Cancer. Cancers. 2022; 14(18):4417.
https://doi.org/10.3390/cancers14184417
Chicago/Turabian Style
Hofste, Lisa S. M., Maartje J. Geerlings, Daniel von Rhein, Sofie H. Tolmeijer, Marjan M. Weiss, Christian Gilissen, Tom Hofste, Linda M. Garms, Marcel J. R. Janssen, Heidi Rütten,
and et al. 2022. "Circulating Tumor DNA-Based Disease Monitoring of Patients with Locally Advanced Esophageal Cancer" Cancers 14, no. 18: 4417.
https://doi.org/10.3390/cancers14184417
APA Style
Hofste, L. S. M., Geerlings, M. J., von Rhein, D., Tolmeijer, S. H., Weiss, M. M., Gilissen, C., Hofste, T., Garms, L. M., Janssen, M. J. R., Rütten, H., Rosman, C., van der Post, R. S., Klarenbeek, B. R., & Ligtenberg, M. J. L.
(2022). Circulating Tumor DNA-Based Disease Monitoring of Patients with Locally Advanced Esophageal Cancer. Cancers, 14(18), 4417.
https://doi.org/10.3390/cancers14184417